Eyetelligence is expanding with the appointment of Babak Asgari as the new Director of Business Development APAC.

An entirely new class of drugs that can repair organ damage caused by degenerative diseases, rather than merely preventing further damage, is expected to

Eye care professionals are invited to participate in a one-day hybrid conference focussed on interdisciplinary care of people living with diabetes.

Apellis has identified a possible culprit for the safety events affecting a small number of patients who received its geographic atrophy (GA) treatment —